These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21616081)

  • 1. Monte Carlo study of the formation and conformational properties of dimers of Aβ42 variants.
    Mitternacht S; Staneva I; Härd T; Irbäck A
    J Mol Biol; 2011 Jul; 410(2):357-67. PubMed ID: 21616081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the folding free-energy landscapes of Abeta42 variants with different aggregation properties.
    Mitternacht S; Staneva I; Härd T; Irbäck A
    Proteins; 2010 Sep; 78(12):2600-8. PubMed ID: 20589631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disordered versus fibril-like amyloid β (25-35) dimers in water: structure and thermodynamics.
    Kittner M; Knecht V
    J Phys Chem B; 2010 Nov; 114(46):15288-95. PubMed ID: 20964446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of G33A and G33I mutations on the structures of monomer and dimer of the amyloid-β fragment 29-42 by replica exchange molecular dynamics simulations.
    Lu Y; Wei G; Derreumaux P
    J Phys Chem B; 2011 Feb; 115(5):1282-8. PubMed ID: 21186801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations to investigate the structural stability and aggregation behavior of the GGVVIA oligomers derived from amyloid beta peptide.
    Chang LK; Zhao JH; Liu HL; Liu KT; Chen JT; Tsai WB; Ho Y
    J Biomol Struct Dyn; 2009 Jun; 26(6):731-40. PubMed ID: 19385701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-beta42 oligomer structures from fibrils: a systematic molecular dynamics study.
    Horn AH; Sticht H
    J Phys Chem B; 2010 Feb; 114(6):2219-26. PubMed ID: 20104925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
    Chong SH; Yim J; Ham S
    Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation.
    Jeong JS; Ansaloni A; Mezzenga R; Lashuel HA; Dietler G
    J Mol Biol; 2013 May; 425(10):1765-81. PubMed ID: 23415897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Arctic mutation alters helix length and type in the 11-28 beta-amyloid peptide monomer-CD, NMR and MD studies in an SDS micelle.
    Rodziewicz-Motowidło S; Czaplewska P; Sikorska E; Spodzieja M; Kołodziejczyk AS
    J Struct Biol; 2008 Nov; 164(2):199-209. PubMed ID: 18765285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
    Lee C; Ham S
    J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural diversity of dimers of the Alzheimer amyloid-beta(25-35) peptide and polymorphism of the resulting fibrils.
    Wei G; Jewett AI; Shea JE
    Phys Chem Chem Phys; 2010 Apr; 12(14):3622-9. PubMed ID: 20336261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease.
    Ngo S; Guo Z
    Biochem Biophys Res Commun; 2011 Oct; 414(3):512-6. PubMed ID: 21986527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Protective Cross-Interaction between Wild-Type and A2T Variants Alters Aβ
    Das P; Chacko AR; Belfort G
    ACS Chem Neurosci; 2017 Mar; 8(3):606-618. PubMed ID: 28292185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations and free energy analyses on the dimer formation of an amyloidogenic heptapeptide from human beta2-microglobulin: implication for the protofibril structure.
    Lei H; Wu C; Wang Z; Duan Y
    J Mol Biol; 2006 Mar; 356(4):1049-63. PubMed ID: 16403526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
    Viet MH; Li MS
    J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations.
    Huet A; Derreumaux P
    Biophys J; 2006 Nov; 91(10):3829-40. PubMed ID: 16891372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimerization of the full-length Alzheimer amyloid β-peptide (Aβ42) in explicit aqueous solution: a molecular dynamics study.
    Zhu X; Bora RP; Barman A; Singh R; Prabhakar R
    J Phys Chem B; 2012 Apr; 116(15):4405-16. PubMed ID: 22448932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.